English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse
  1. View item / 
  2. Item Summary

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model

MPS-Authors
/persons/resource/persons188401

Costa,  Giulia
Vector Biology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons82016

Levashina,  Elena
Vector Biology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

s41541-023-00653-7.pdf
(Publisher version), 3MB

Supplementary Material (public)
There is no public supplementary material available
Citation

Ludwig, J., Scally, S. W., Costa, G., Hoffmann, S., Murugan, R., Lossin, J., et al. (2023). Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model. NPJ Vaccines, 8(1).


Cite as: https://hdl.handle.net/21.11116/0000-000D-2EA1-A
Abstract
There is no abstract available